Stocks and Investing Stocks and Investing
Tue, February 18, 2020
Fri, February 14, 2020
Thu, February 13, 2020
Wed, February 12, 2020
Tue, February 11, 2020

David Risinger Maintained (BHC) at Buy with Decreased Target to $32 on, Feb 11th, 2020


Published on 2024-10-26 21:43:58 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Maintained "Bausch Health Companies Inc." (BHC) at Buy with Decreased Target from $34 to $32 on, Feb 11th, 2020.

David has made no other calls on BHC in the last 4 months.



There are 3 other peers that have a rating on BHC. Out of the 3 peers that are also analyzing BHC, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $39 on, Monday, December 30th, 2019
  • Chris Schott of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $38 on, Thursday, December 12th, 2019
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $60 on, Monday, December 2nd, 2019